These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3511964)

  • 1. Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues.
    Stone SR; Morrison JF
    Biochim Biophys Acta; 1986 Feb; 869(3):275-85. PubMed ID: 3511964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogues.
    Stone SR; Montgomery JA; Morrison JF
    Biochem Pharmacol; 1984 Jan; 33(2):175-9. PubMed ID: 6367748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular dichroism studies of dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli B, MB 1428: ternary complexes.
    Greenfield NJ
    Biochim Biophys Acta; 1975 Sep; 403(1):32-46. PubMed ID: 240430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
    Sirotnak FM
    Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
    [No Abstract]   [Full Text] [Related]  

  • 5. The pH-dependence of the binding of dihydrofolate and substrate analogues to dihydrofolate reductase from Escherichia coli.
    Stone SR; Morrison JF
    Biochim Biophys Acta; 1983 Jun; 745(3):247-58. PubMed ID: 6344924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrofolate reductases in some folate-requiring bacteria with low trimethoprim susceptibility.
    Then RL; Riggenbach H
    Antimicrob Agents Chemother; 1978 Jul; 14(1):112-7. PubMed ID: 686702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular dichroism studies in the near UV of ligand binding to chicken liver dihydrofolate reductase.
    Seng G; Bolard J
    Biochimie; 1983 Mar; 65(3):169-75. PubMed ID: 6405809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic study of dihydrofolate reductase inhibitor selectivity.
    Sasso SP; Gilli RM; Sari JC; Rimet OS; Briand CM
    Biochim Biophys Acta; 1994 Jul; 1207(1):74-9. PubMed ID: 8043612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamic study of folate analogue binding to dihydrofolate reductases from different species.
    Sasso S; Gilli R; Lopez C; Sari JC; Briand C
    Adv Exp Med Biol; 1993; 338():521-4. PubMed ID: 8304171
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of conversion of phenylalanine-31 to leucine on the function of human dihydrofolate reductase.
    Prendergast NJ; Appleman JR; Delcamp TJ; Blakley RL; Freisheim JH
    Biochemistry; 1989 May; 28(11):4645-50. PubMed ID: 2765506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive inhibition of folate absorption by dihydrofolate reductase inhibitors, trimethoprim and pyrimethamine.
    Zimmerman J; Selhub J; Rosenberg IH
    Am J Clin Nutr; 1987 Sep; 46(3):518-22. PubMed ID: 3630970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity labeling of dihydrofolate reductase with an antifolate glyoxal.
    Johanson RA; Henkin J
    J Biol Chem; 1985 Feb; 260(3):1465-74. PubMed ID: 3881433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorescence study of substrate and inhibitor binding to bovine liver dihydrofolate reductase.
    Degan P; Carpano P; Cercignani G; Montagnoli G
    Int J Biochem; 1989; 21(3):291-5. PubMed ID: 2744204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrofolate reductase hysteresis and its effect of inhibitor binding analyses.
    Baccanari DP; Joyner SS
    Biochemistry; 1981 Mar; 20(7):1710-6. PubMed ID: 7013798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrofolate reductase from Eimeria tenella: rationalization of chemotherapeutic efficacy of pyrimethamine.
    Wang CC; Stotish RL; Poe M
    J Protozool; 1975 Nov; 22(4):564-8. PubMed ID: 1059772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering specificity for folate into dihydrofolate reductase from Escherichia coli.
    Posner BA; Li L; Bethell R; Tsuji T; Benkovic SJ
    Biochemistry; 1996 Feb; 35(5):1653-63. PubMed ID: 8634297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular-dichroism studies of ligand binding to dihydrofolate reductase from Lactobacillus casei MTX/R.
    Hood K; Bayley PM; Roberts GC
    Biochem J; 1979 Feb; 177(2):425-32. PubMed ID: 35152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate.
    Zolli-Juran M; Cechetto JD; Hartlen R; Daigle DM; Brown ED
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2493-6. PubMed ID: 12852950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of tightly bound substrates in pure preparations of dihydrofolate reductase: implications for studies on enzymes.
    Williams EA; Morrison JF
    Biochim Biophys Acta; 1991 May; 1078(1):47-55. PubMed ID: 2049383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells.
    Boarman DM; Baram J; Allegra CJ
    Biochem Pharmacol; 1990 Dec; 40(12):2651-60. PubMed ID: 2260989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.